Dogwood Therapeutics, Inc. Common Stock
Market Cap
56M
Short interest (May 15)
0.3%
Net Short (Jun 03 ): 0.0%
Borrow Fee
1.73%
↓ 43.7%
Available Shares
3M
↑ 31.2%
Price Chart
Company Overview
Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.